Pharmacy on Adult Diabetic Hepatitis B Immunization
Received Date: Feb 21, 2023 / Published Date: Mar 17, 2023
Abstract
Acute or chronic liver infection brought on by the Hepatitis B virus is known as hepatitis B (HepB) (HBV). 1 The Centers for Disease Control and Prevention (CDC) recorded 3192 cases of acute HBV infection in the United States in 2019. However, the actual number of cases is thought to be 6.5 times higher than the reported cases at any given time, with cases facing a 15–25 percent risk of untimely death from cirrhosis or liver cancer and the actuality of ethnic and ethnic differences in habit frequency. Habitual HBV infection also continues to be a serious public health issue. In response, the Viral Hepatitis National Strategy Plan for the United States 2021–2025 was published by the Department of Health and Human Services (HHS) to eliminate viral hepatitis as a concern.
Citation: Cumbay M (2023) Pharmacy on Adult Diabetic Hepatitis B Immunization. J Mol Pharm Org Process Res 11: 164.
Copyright: © 2023 Cumbay M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Usage
- Total views: 460
- [From(publication date): 0-2023 - Apr 28, 2024]
- Breakdown by view type
- HTML page views: 396
- PDF downloads: 64
